New documents have revealed that DePuy Orthopaedics, a unit of New Jersey-based Johnson & Johnson, continued to sell faulty hip replacement joints internationally after they were rejected for sale by the U.S. Food and Drug Administration. At the same time, DePuy sold a similar defective product in the U.S. after was approved through the FDA's 501(k) loophole, which we detailed extensively in a previous product liability blog post.
Recently, the faulty metal-on-metal hip replacement joints manufactured by DePuy Orthopaedics, a unit of New Jersey-based Johnson & Johnson, have become the subject of scrutiny and debate after causing pain and injury to thousands of patients. According to a few new studies, those defective products may continue to cause harm long after they are removed from the body.
Last week, we wrote that the U.S. Food and Drug Administration had ordered additional research into the vaginal mesh products that have caused injury and even death to women throughout the country.
Earlier this week, we wrote about the recent influx of product liability lawsuits against New Jersey-based Johnson & Johnson regarding its vaginal mesh implant products, which have resulted in injury and death in hundreds of women throughout the country. The vaginal mesh suits are not the only litigation facing Johnson & Johnson at this time. The company is also defending itself against a growing class action products liability lawsuit after "mechanical failure" forced the recall of hundreds of artificial joints.
Two New Jersey-based companies are among the more than 30 businesses that must conduct studies and clinical trials on the safety and effectiveness of vaginal mesh implants, according to recent media reports. The U.S. Food and Drug Administration ordered the studies after receiving multiple reports of injuries and fatalities caused by the defective products, an agency spokesman said.
More than two years ago, the Campaign for Safe Cosmetics released a report aiming to call attention to the fact that several of Johnson & Johnson baby shampoo product contains two carcinogens which could potentially cause lasting harm to babies and their parents. The campaign recently released a second report, alerting parents that Johnson & Johnson has not altered the chemical makeup of that dangerous product, leaving millions of babies at risk.
Pharmaceutical giant Johnson & Johnson has won the dubious honor of being named the most sued company in New Jersey for 2010. The company defended 63 lawsuits in the state last year, the majority of which were products liability lawsuits based on the harmful side effects of Johnson & Johnson medication. Other companies near the top of the most sued list range from pharmaceutical companies such as Merck and Bristol-Meyers Squibb, retailers such as Wal-Mart, and large banks and mortgage lenders.
In recent months, health care product manufacturer Johnson & Johnson has been the subject of multiple recalls and products liability lawsuits after numerous complaints about several of the company's products ranging from children's pain relievers to birth control medication to artificial hips. Because of these seemingly continual product malfunctions, it hardly even seems newsworthy when a new Johnson & Johnson recall is announced. However, the importance of the items manufactured by the company - medication, infant and child care products, health care necessities - it is important to continue to pay attention when Johnson & Johnson announces yet another recall, as it did late last week.
Earlier this week, we wrote about Johnson & Johnson unit DePuy Orthopaedics and the contention that its A.S.R. hip replacement implant is a defective product. When the A.S.R. was introduced, it was promoted as a major breakthrough, and as an implant that would last much longer than similar products. When the allegations were first brought against DePuy, the company maintained its self-promotion, claiming that surgical mistake was behind patients' pain and injury, not the product itself. Recently, however, DePuy announced that it is phasing out the A.S.R. device, but not for safety reasons. Instead, the company claims that lagging sales are behind the recall.
Over the last year, health care product manufacturer Johnson & Johnson has come under scrutiny after multiple allegations of injuries caused by various products. On this blog alone, we have written about the harm reportedly caused by the birth control patch and children's over-the-counter cold medicines, both of which have given rise to products liability litigation. Recently, a new controversy has risen after claims that an artificial replacement hip manufactured by DePuy Orthopaedics, a unit of Johnson & Johnson, was not only failing, but causing serious and lasting harm to patients.